


CHAIN Biotechnology Revenue
Biotechnology Research • Marlow, England, United Kingdom • 11-20 Employees
CHAIN Biotechnology revenue & valuation
| Annual revenue | $1,026,660 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $3,300,000 |
| Total funding | $2,300,000 |
Key Contacts at CHAIN Biotechnology
Matthew Duchars
Chief Executive Officer
Zahid Bashir
Non Executive Director
Company overview
| Headquarters | Jubilee House, Third Avenue, Marlow, SL7 1EY, GB |
| Phone number | +441157840106 |
| Website | |
| SIC | 873 |
| Keywords | Microbiology, Synthetic Biology, Microbiome, Metabolic Engineering, Anaerobe, Chiral Chemical Synthesis, Clostridia |
| Founded | 2014 |
| Employees | 11-20 |
| Socials |
CHAIN Biotechnology Email Formats
CHAIN Biotechnology uses 2 email formats. The most common is {first name}.{last name} (e.g., john.doe@chainbiotech.com), used 80% of the time.
| Format | Example | Percentage |
|---|---|---|
{first name}.{last name} | john.doe@chainbiotech.com | 80% |
{first initial}.{last name} | j.doe@chainbiotech.com | 20% |
About CHAIN Biotechnology
CHAIN Biotechnology was founded in 2014, by serial entrepreneur Dr Edward Green, to exploit the therapeutic potential of Clostridia bacteria found in the human gut microbiome. CHAIN has built an impressive technical team of molecular biology, microbiology, microbiome and fermentation specialists focused on the biotechnology development of Clostridia. In addition, CHAIN leverages synthetic biology expertise from the Synthetic Biology Research Centre at the University of Nottingham. CHAIN has developed a proprietary microbial platform for drug delivery. The platform builds on core engineering skills and involves the development and use of engineered Clostridia to deliver specific therapeutics to the gut. CHAIN’s Clostridium Assisted Drug Delivery (CADD™) delivery platform is highly differentiated and supports a therapeutic product pipeline for a wide range of clinical indications including localised infection, inflammation and CNS signalling. Our lead asset is an engineered strain that secretes a novel and potent anti-inflammatory molecule targeting Inflammatory Bowel Disease, a chronic gut disease affecting millions worldwide.
Employees by Management Level
Total employees: 11-20
Seniority
Employees
Employees by Department
CHAIN Biotechnology has 4 employees across 3 departments.
Departments
Number of employees
CHAIN Biotechnology Tech Stack
Discover the technologies and tools that power CHAIN Biotechnology's digital infrastructure, from frameworks to analytics platforms.
Font scripts
JavaScript libraries
Reverse proxies
Form builders
Programming languages
Font scripts
Blogs
Maps
Databases
Page builders
Font scripts
Frequently asked questions
4.8
40,000 users



